Curcumin and Cancer

被引：766
作者：
Giordano, Antonio [1 ,2 ]
Tommonaro, Giuseppina [3 ]
机构：
[1] Temple Univ, Sbarro Inst Canc Res & Mol Med, BioLife Sci Bldg,Suite 431-1900 N 12th St, Philadelphia, PA 19122 USA
[2] Temple Univ, Ctr Biotechnol, Coll Sci & Technol, BioLife Sci Bldg,Suite 431-1900 N 12th St, Philadelphia, PA 19122 USA
[3] Natl Res Council Italy, Inst Biomol Chem, Via Campi Flegrei 34, I-80078 Pozzuoli, Italy
来源：
NUTRIENTS | 2019年 / 11卷 / 10期
关键词：
curcumin; cancer; cell signaling pathways; Curcuma longa; NF-KAPPA-B; CELL-CYCLE ARREST; WT1; GENE-EXPRESSION; GROWTH IN-VITRO; DOWN-REGULATION; SUPPRESSES PROLIFERATION; SIGNALING PATHWAY; INHIBITS PROLIFERATION; ANTITUMOR-ACTIVITY; MOLECULAR TARGETS;
D O I：
10.3390/nu11102376
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
Curcumin, a polyphenol extracted from Curcuma longa in 1815, has gained attention from scientists worldwide for its biological activities (e.g., antioxidant, anti-inflammatory, antimicrobial, antiviral), among which its anticancer potential has been the most described and still remains under investigation. The present review focuses on the cell signaling pathways involved in cancer development and proliferation, and which are targeted by curcumin. Curcumin has been reported to modulate growth factors, enzymes, transcription factors, kinase, inflammatory cytokines, and proapoptotic (by upregulation) and antiapoptotic (by downregulation) proteins. This polyphenol compound, alone or combined with other agents, could represent an effective drug for cancer therapy.
引用
收藏
页数：20
相关论文
共 136 条
[1]   Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer - Modern target but ancient solution [J].
Aggarwal, Bharat B. ;
Sethi, Gautam ;
Ahn, Kwang Seok ;
Sandur, Santosh K. ;
Pandey, Manoj K. ;
Kunnumakkara, Ajaikumar B. ;
Sung, Bokyung ;
Ichikawa, Haruyo .
SIGNAL TRANSDUCTION PATHWAYS, PT B: STRESS SIGNALING AND TRANSCRIPTIONAL CONTROL, 2006, 1091 :151-169
[2]   Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells [J].
Akkoc, Yunus ;
Berrak, Ozge ;
Arisan, Elif Damla ;
Obakan, Pinar ;
Coker-Gurkan, Ajda ;
Palavan-Unsal, Narcin .
BIOMEDICINE & PHARMACOTHERAPY, 2015, 71 :161-171
[3]   Awareness and current knowledge of breast cancer [J].
Akram, Muhammad ;
Iqbal, Mehwish ;
Daniyal, Muhammad ;
Khan, Asmat Ullah .
BIOLOGICAL RESEARCH, 2017, 50
[4]   Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes [J].
Al-Ejeh, F. ;
Kumar, R. ;
Wiegmans, A. ;
Lakhani, S. R. ;
Brown, M. P. ;
Khanna, K. K. .
ONCOGENE, 2010, 29 (46) :6085-6098
[5]   Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways [J].
Allegra, Alessandro ;
Speciale, Antonio ;
Molonia, Maria Sofia ;
Guglielmo, Letterio ;
Musolino, Caterina ;
Ferlazzo, Guido ;
Costa, Gregorio ;
Saija, Antonella ;
Cimino, Francesco .
TOXICOLOGY IN VITRO, 2018, 47 :186-194
[6]   Curcumin and cancer: An "old-age" disease with an "age-old" solution [J].
Anand, Preetha ;
Sundaram, Chitra ;
Jhurani, Sonia ;
Kunnumakkara, Ajaikumar B. ;
Aggarwal, Bharat B. .
CANCER LETTERS, 2008, 267 (01) :133-164
[7]  
[Anonymous], 2015, Cancer Facts Figures 2015
[8]   A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95® CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin [J].
Antony, B. ;
Merina, B. ;
Iyer, V. S. ;
Judy, N. ;
Lennertz, K. ;
Joyal, S. .
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 70 (04) :445-449
[9]   Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells [J].
Anuchapreeda, S ;
Limtrakul, P ;
Thanarattanalkorn, P ;
Sittipreechacharn, S ;
Chanarat, P .
ARCHIVES OF PHARMACAL RESEARCH, 2006, 29 (01) :80-87
[10]   Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines [J].
Anuchapreeda, Songyot ;
Tima, Singkome ;
Duangrat, Chadarat ;
Limtrakul, Pornngarm .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (04) :585-594
12345678910